Board Login / Members Only
The Albert Einstein College of Medicine in Bronx, New York offers a two-year postdoctoral fellowship in Psycho-Oncology to begin July/August 2020.
REQUIREMENTS: A doctoral degree (Ph.D. or Psy.D.) in psychology or allied field.
PROGRAM OVERVIEW: The fellow would train under licensed health psychologist and founding director of The Bronx Oncology Living Daily (BOLD) Program and work within a compassionate and hardworking team towards learning the skills for developing, implementing, and evaluating culturally-responsive cancer wellness services tailored to a diverse and underserved population.
The training emphasis of this fellowship is 50% research/program coordination, 30% mentoring others, and 20% clinical.
The Fellow would be involved in all aspects of this community-based Cancer Wellness Program including:
To apply for this position, please EMAIL your CV with a cover letter to:
Learn More about BOLD here:
Register quickly, spaces are limited!
Date and time: Thursday, June 18, 2020 4 to 5:30 p.m. ET (LIVE)
Discuss the experience in different countries of cancer patients, families, and healthcare professionals during the COVID-19 pandemic. Outline challenges, opportunities, and strategies to optimize care on the level of public policy, research, clinical care, and training. Define needs for collaboration in these areas, with the potential creation of eventual working groups.
Methods: We have the pleasure of having an invited speaker, Jim Davidson, who will talk about how to maintain a resilient mindset in the face of adversity, resilient teamwork, and resilient leadership. The Q&A period will be followed by a panel discussion initiated by senior IPOS members Dr. Jane Turner, Dr. David Kissane, Dr. Gary Rodin, and Dr. Chioma Asuzu.
Here’s a sneak peek of what to expect: https://www.youtube.com/watch?v=t2g6hk3OU-M
Jim Davidson is a resilience expert, an expedition leader, and a New York Times best-selling author. From his 36 years of adventure and survival, Jim distills compelling stories and uplifting lessons about how to overcome change, challenge and uncertainty through resilience.
He shares motivating keynotes and workshops on personal resilience, resilient teamwork and resilient leadership. Jim has scaled high peaks from Argentina to Nepal, from Bolivia to Tibet. The US National Park Service has commended Jim twice for volunteering for successful high-altitude rescues in Colorado and Alaska.
While first attempting to ascend Mt. Everest in 2015, Jim and his partners survived massive earthquakes and avalanches. He shared his incredible experiences and insights with CNN, CBS, ABC, NBC, Smithsonian Channel, PBS and more. Jim told his story of surviving the earthquake in the National Geographic TV Show “Witness to Disaster”. In 2017, Jim returned to Mount Everest and summited successfully. For 20 years. Jim worked as a hydrogeologist (B.S. & M.S. degrees) and ran his own environmental consulting firm. Earlier he worked as an industrial painter on high-voltage electrical towers carrying 230,000 volts.
Jim co-authored the New York Times best-selling survival memoir, "The Ledge: An Inspirational Story of Friendship and Survival". The Ledge won the National Outdoor Book Award for Outdoor Literature, and was picked one of the Best Books of the Year by Amazon. His epic survival story was featured in an international TV episode of "I Shouldn't Be Alive" on the Discovery Channel.
Panel discussants: Dr. Jane Turner, Dr. David Kissane, Dr. Gary Rodin, Dr. Chioma Asuzu
Chair: Dr. Melissa Henry
Did you submit an abstract to the 22nd Annual IPOS World Congress and was ACCEPTED? If yes, we have some important dates and options now that the congress has been postponed to 2021.
YES OR NO TO KEEPING YOUR APPROVED ABSTRACT FOR THE NEW 2021 DATES?
You need to confirm by no later than August 1, 2020 if you wish to keep your abstract(s) in place or withdraw. Please email [email protected] with your abstract number(s) with a YES or NO option for each.
WANT TO UPDATE YOUR APPROVED ABSTRACT & KEEP AS THE SAME PRESENTATION TYPE?
If you want to update your abstract content, you must update by no later than December 1, 2020. Updating will be available on the same form when your abstract was submitted. Please note your abstract will still be deemed accepted and will not undergo another evaluation process after updated.
WANT TO UPDATE YOUR APPROVED ABSTRACT BUT HAVE CONSIDERED FOR A DIFFERENT PRESENTATION TYPE?
You need to email [email protected] with your abstract(s) numbers to WITHDRAW from the 22nd Annual World Congress. From there, you can RESUBMIT an updated abstract on or before December 1, 2020 with your desired presentation type. Please note that your updated abstract will go through a FULL evaluation process with acceptance not guaranteed.
WANT TO SUBMIT NEW ABSTRACTS?
With the postponement of the Congress comes the ability to submit new abstracts of all types. Details on when and how to submit will be made available shortly. The submission deadline will be December 1, 2020.
WHAT ARE THE NEW CONGRESS DATES?
· Wednesday 26th May 2021: IPOS Academy Workshops
· Thursday 27th May 2021: IPOS 2021 Day 1
· Friday 28th May 2021: IPOS 2021 Day 2
· Saturday 29th May 2021: IPOS 2021 Day 3
The venue for the revised dates remains the same – International Conference Center, Kyoto.
If you have any questions or comments, please direct to [email protected]
The everyday life of all people continues to change further from normal to extraordinary around the globe. The COVID-19 pandemic continues to be of great concern to all and has been the subject of much ongoing discussion between the members of the IPOS 2020 World Congress Scientific committee and the IPOS Board of Directors.
For the second time, we have decided to postpone the Congress. All parties involved agree that it is not safe or viable to hold in 2020. As a result, the 22nd Annual IPOS World Congress will be held in Kyoto, Japan in May 2021 as per the dates listed below. These dates reflect the nature of the Congress, which is a shared initiative between IPOS and the Japanese Psycho-Oncology Society and takes into account the venue availability in Japan.
All registered delegates, invited speakers, and sponsors will be sent additional details within 30 days shortly. For all bookings/payments made through the meeting website (registration, hotel, workshops, dinner, content capture), delegates will be given the option to have these bookings automatically transferred to the May 2021 meeting or to request a refund. All accepted abstracts are being honored for the May 2021 meeting. Individuals will also have the option to update or withdraw submitted abstract.
Please change or cancel any travel or hotel arrangements you have made independently. Most airlines are currently waiving change fees and providing a full credit for tickets that normally do not allow changes.
Member of the IPOS Board are enormously grateful to our colleagues from the Japanese Psycho-Oncology Society who have been both responsive and gracious throughout our discussions. Our deepest concerns are for our colleagues whose personal and professional lives have been impacted by this pandemic and our ongoing support for them, which I know will be offered by our IPOS community, is so important.
If you have any questions or comments, please direct to [email protected]
Stay safe and see you in 2021!
Jane Turner, MBBS,PhD, FRANZCP
President, International Psycho-Oncology Society
Yosuke Uchitomi, MD, PhD
Chair, 22nd World Congress of Psycho-Oncology
During these difficult COVID – 19 times, IPOS remains committed to promoting the highest standards of comprehensive cancer care. More than ever, we are united in our mission to promote global excellence in psychosocial care for people affected by cancer through partnerships, research, public policy, advocacy and education.
We wish to highlight the additional burden brought to patients with cancer worldwide of having to cope with a pandemic. Patients and families are frightened about not receiving proper treatment as resources are stratified according to priorities. Isolation directives to mitigate infection risk means some patients cannot access supports to address important physical, psychological, social, and spiritual needs. There are fears about contracting COVID-19 when one’s immunity system is already low. Patients struggling with common physical symptoms related to their cancer or treatments may be frightened of having contracted the virus. They can be afraid of coming to the hospital, now perceived as a potential risk for their health. They may present later for conditions requiring immediate attention. They may not be able to be accompanied during treatments and important surgical procedures. Healthcare may be fragmented, as many disciplines work from home and treatments are outsourced to community settings. Patients that are hospitalized may not be allowed to have visitors, and those at the end-of-life may not be visited by their circle of family and friends, as travel bans, and hospital restrictions, prevail. Some patients may feel that they are abandoned as they are no longer benefitting from the previous reassuring structure of the oncology setting. Others feel normalized as now everyone is socially isolated and staying at home. When they had previously considered themselves as different, being at home is now a new normal, with its de-stigmatizing effect.
We need to flexibly develop services to respond to the complex needs of patients throughout their cancer trajectory from discovery of symptoms to end-of-life care and bereavement. We have seen a rapid uptake of telemedicine and tele-conferencing allowing for needed cancer care and follow-up of oncology patients and their families. Patients and their families can now have access to cancer care from their very homes. Guidelines for telemedicine and tele-conferencing can be found here: https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/apa-resources-on-telepsychiatry-and-covid-19
As patients are presenting less to the hospital, it becomes crucial to develop new means of identifying their distress. There have been multiple initiatives of patient portals allowing for screening for distress at a distance, which appears particularly important in our pandemic times to make sure needs are met. Guidelines for screening for distress can be found here:
Cancer care needs to be equitable. Face-to-face contact via telemedicine and screening for distress via a portal are not available for patients that do not have a computer or internet access, which may create further inequities in symptom management, functional rehabilitation, psychosocial care, and survival. We need to develop innovative solutions and services to fill this important gap in partnership with companies and other stakeholders.
Healthcare providers have needed to readjust to a number of stressful changes in the organization of their workforce and of the healthcare system. Caring for COVID-19 patients, on the backdrop of a system with limited resources to protect them, creates a stressful context fertile to burnout and vicarious traumatisation. More than even, healthcare settings need to develop ways to nurture their workforce. Guidelines for healthcare workers ca be found here: https://www.psychiatry.org/news-room/apa-blogs/apa-blog/2020/02/coronavirus-and-mental-health-taking-care-of-ourselves-during-infectious-disease-outbreaks
For resources on stress and coping during the coronavirus crisis, please visit: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/managing-stress-anxiety.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fmanaging-stress-anxiety.html
For resources on caring for children, please visit: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children.html
Dr. Melissa Henry
Associate Professor, Faculty of Medicine, Department of Oncology, McGill University
FRQS Clinician-Scientist, McGill University
Director, Psycho-Oncology Research Group
Lady-Davis Institute for Medical Research, Jewish General Hospital
IN THIS ISSUE:
1. Psychological distress in newly diagnosed breast cancer patients: an observational study comparing those at high risk of hereditary cancer with those of unknown risk
2. Shared experiences of diagnosis and treatment of young-onset colorectal cancer: a patient-oriented qualitative study
3. Exploring the knowledge and attitudes about cancer of older adults in Barcelona, Spain
4. Caregivers’ perception of psychosocial issues of pediatric patients with osteosarcoma: an exploratory study
FIND OUT MORE BY GOING TO https://journals.lww.com/jporp/pages/currenttoc.aspx
The COVID-19 pandemic is of concern to all and has been the subject of much discussion between the members of the IPOS 2020 World Congress Scientific committee and the IPOS Board.
We have decided to postpone the meeting which was to be held in Kyoto from 16-19 June 2020 until August 2020 as per the dates listed below. These dates reflect the nature of the Congress which is a shared initiative between IPOS and the Japanese Psycho-Oncology Society and take into account specific religious and holiday observances in Japan.
The venue for the revised dates remains the same – International Conference Centre, Kyoto
It is not possible to reschedule the Congress in Kyoto to any other time because the venue is not available. Rescheduling rather than cancelling means that IPOS does not face a financial penalty.
The health and wellbeing of our members and the patients and communities to which they would return after the Congress is uppermost in our decision-making. We recognise that the situation is evolving rapidly and will maintain vigilance as we move towards our re-scheduled meeting in August.
For more information, please go to http://ipos2020.com/
The 4th International Conference on Integrative Oncology, ICIO2020, Kochi
The Psycho-Oncology session was a collective work of International Conference on Integrative Oncology (ICIO) 2020, International Psycho-Oncology Society (IPOS) and Global Homeopathy Foundation (GHF).
It was the first time ever that a psycho-oncology session included into this international conference with over 700 attendees and 50 speakers.
This session was coordinated by Dr. Veenavani Nallepalli, IPOS member.
Ozan BAHCIVAN from Turkey, the Former Director of IPOS who joined the enlightened the audience on what role Psycho-Oncology plays in cancer care and also the evolution of it in medical history and also the involvement and works of IPOS. He also highlighted that we don't treat the disease but the patient as a whole, emphasising on holistic approach and also spoke about the forthcoming IPOS congress that is to be held from 16-19 June 2020 in Kyoto, Japan.
The session also included a video message by Dr. Jane Turner, IPOS President addressing the Congress about various domains of Psycho-social aspects of cancer care and the need of services and about the extensive works of IPOS.
Dr. E. Vidhubala, Director of Nellai Cancer Centre emphasised on the need of early detection and screening in Primary and secondary health care to Prevent cancer. She also discussed the continuum-gaps of Cancer care.
Dr. Surendran Veeraiah, HOD, Psycho-Oncology department, Cancer Institute, Adyar, Chennai gave the complete picture of Psycho-social aspects of Cancer care and also the need of Assessments like Pain and Distress which helps a lot in the treatment modality. He also discussed on the concerns of the caregivers and how Psycho Oncology is helpful to tackle it.
IPOS is pleased to report that in February 2020, the Executive Board of the World Health Organization (WHO) voted to approve our continued official relations with them as a non-state actor. We are one of 66 organizations around the world with this status.
With our support, IPOS provided feedback in January to WHO on:
WHO Report on Cancer: Setting priorities, investing wisely and providing care for all
We look forward to our continued relationship with WHO.
Organizing Chair: Dr. Surendran Veeraiah
Organizer: Department of Psycho-oncology, Cancer Institute (WIA)
Time: 31st January & 1st February, 2020
The International Psycho-Oncology Society Academy 2020 was held in Chennai, India from 31st January to 1st February, 2020. The Academy was organized by the Department of Psychooncology in Cancer Institute (WIA), one of the national comprehensive cancer centers in India. The focus of the Academy was on ‘Enhancing Psychosocial Practices and Research in India’ and the goal of the program was to train the practicing psycho-oncology professionals on therapeutic skills, strengthening research orientation and networking professionals across the country. The program featured significant inputs from psycho-oncologists, psychiatrists, oncologists, physiotherapists, survivors. Around 130 participants representing various cancer centers across the country attended the program and contributed enthusiastically.
Pre-conference Workshop (Day 1)
The Academy was declared open on 31st January with four parallel pre-conference workshops. This included workshops on Introduction to Level-1 CBT Skills and Management of Specific Symptoms- Chronic Pain, Insomnia and Fatigue by Dr. Maggie Watson, Concept development in research by Dr. Haryana Dhillon, Communication in Oncology by Prof. Richard Fielding and Implementation research: Understanding Principles and Considering Research Applications in Psycho-oncology by Dr. Sudha Sivaram. A total of 130 participants attended the pre-conference workshops with around 40 participants in each. The participants stated that the workshops were of high quality and of great learning experience.
Conference (Day 2)
The day 2 of the Academy was organized as a conference featuring three symposiums, two panel discussion, two plenaries and two master classes. The speakers included eminent psychooncologists, oncologists, psychiatrists, physiotherapists, survivors from across the country. The sessions featured important inputs from the speakers on the psychosocial, behavioural aspects of cancer care in India with special attention to the way forward. Recent updates in psychotherapies by Dr. Maggie Watson, Emerging trends and strengthening psycho-oncology research in India by Prof. Richard Fielding, Establishing psycho-oncology collaborative study groups by Dr. Haryana Dhillon, panel discussions on communication in oncology moderated by Dr Prasanth Ganesan and rehabilitation of cancer survivors by Dr Ramanan were few sessions rated highly significant by the attendees. In addition to the scientific sessions, oral and e-poster presentations were facilitated evaluated by Dr Subathra Jeyaram, Dr Soumitra Datta and Mr M.S Satish. Around 34 abstracts were received and were evaluated anonymously by the scientific committee to be chosen for oral and e-poster presentations. Five from the abstracts reviewed were chosen as ‘Best Clinical Implication Paper’ and were awarded during the program.
The Academy was well-received by the participants and they found the sessions intriguing, impactful and essential to their practice.
The Academy concluded with an announcement on the APPON 7 which is to be held by Cancer Institute (WIA) in January 2021 in Chennai. The participants expressed their desire to be a part of and attend the APPON meeting in the following year.
List of national faculties who contributed significantly towards the success of the academy:
Dr. Jayita Deodhar
Dr. Brindha Sitaram
Dr. Chitra Venkateswaran
Ms. Savita Goswami
Dr. Mahati Chittem
Dr. Rejiv Rajendranath
Dr. Krishnakumar Rathinam
Dr. Arun Seshachalam
Dr. Ponni Sivaprakasam
Dr. Vandana Dhamankar
Dr. Arvind Krishnamurthy
Dr. Nikita Mehra
Dr. Anand Raja
Dr. Kalpana Balakrishnan
Mr. Vijay Srinivasan
Dr. Vasanth Christopher
International Psycho-Oncology Society1 - 189 Queen Street East
Toronto, ON M5A 1S2
244 Fifth Avenue, Suite L296
New York, NY 10001
T: +1 416-968-0260
© 2019 International Psycho-Oncology Society
Website powered by Funnel Communications Inc.